News
APUS
5.65
-13.52%
-0.88
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 3d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 4d ago
Weekly Report: what happened at APUS last week (0713-0717)?
Weekly Report · 5d ago
Upcoming Stock Splits This Week (July 20 to July 24) – Stay Invested
TipRanks · 5d ago
Apimeds Pharmaceuticals to Implement Reverse Stock Split July 24
TipRanks · 07/13 21:02
Weekly Report: what happened at APUS last week (0706-0710)?
Weekly Report · 07/13 09:39
Weekly Report: what happened at APUS last week (0629-0703)?
Weekly Report · 07/06 09:41
Weekly Report: what happened at APUS last week (0622-0626)?
Weekly Report · 06/29 09:38
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 06/22 17:05
Weekly Report: what happened at APUS last week (0615-0619)?
Weekly Report · 06/22 09:43
Weekly Report: what happened at APUS last week (0608-0612)?
Weekly Report · 06/15 09:44
Weekly Report: what happened at APUS last week (0601-0605)?
Weekly Report · 06/08 09:41
Weekly Report: what happened at APUS last week (0525-0529)?
Weekly Report · 06/01 09:43
Apimeds Pharmaceuticals Q1 EPS $(2.26) Down From $(0.50) YoY
Benzinga · 05/26 21:32
Weekly Report: what happened at APUS last week (0518-0522)?
Weekly Report · 05/25 09:45
Weekly Report: what happened at APUS last week (0511-0515)?
Weekly Report · 05/18 09:45
Apimeds Pharmaceuticals Delays Quarterly SEC Filing
TipRanks · 05/15 23:34
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 05/11 12:06
Weekly Report: what happened at APUS last week (0504-0508)?
Weekly Report · 05/11 09:43
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 05/07 17:05
More
Webull provides a variety of real-time APUS stock news. You can receive the latest news about APIMEDS PHARMACEUTICALS US INC through multiple platforms. This information may help you make smarter investment decisions.
About APUS
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.